SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Capricor Therapeutics, Inc. CAPR NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Capricor Therapeutics, Inc. (CAPR) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 AKTX, ANAB, BPTH, CBIO, CDTX, DFFN 等.

CAPR 的市值为 $1.6B, 而同行平均市值为 $1.03B. CAPR 显著大于其平均同行.

同行与相似公司 — CAPR

Akari Therapeutics, Plc

$4.77 +3.02% $4.26M

AnaptysBio, Inc.

$67.89 -3.32% $1.95B

Bio-Path Holdings, Inc.

$0.06 +0.80% $587.62K

Catalyst Biosciences, Inc.

$19.95 +2.20% $549.76M

Cidara Therapeutics, Inc.

$221.38 0.00% $5.61B

Diffusion Pharmaceuticals Inc.

$4.40 +10.28% $8.98M

Homology Medicines, Inc.

$0.93 +0.77% $3.02M

IDEAYA Biosciences, Inc.

$32.18 -0.53% $2.83B

Keros Therapeutics, Inc.

$11.71 +1.39% $435.86M

Moleculin Biotech, Inc.

$2.44 -2.01% $2.95M

MeiraGTx Holdings plc

$11.25 -0.35% $916.27M

$12.02 -5.87% $32.21M

其他人也在看

Cidara Therapeutics, Inc.

IDEAYA Biosciences, Inc.

Soleno Therapeutics, Inc.

AnaptysBio, Inc.

MeiraGTx Holdings plc

Catalyst Biosciences, Inc.

Keros Therapeutics, Inc.

Unicycive Therapeutics, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言